The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
The evolving role of statins in the management of atherosclerosis
Open accessAbstract
Significant advances in the management of cardiovascular disease have been made possible by the development of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors--"statins." Initial studies explored the impact of statin therapy on coronary artery disease (CAD) progression and regression. Although the angiographic changes were small, associated clinical responses appeared significant. Subsequent large prospective placebo-controlled clinical trials with statins demonstrated benefit in the secondary and primary prevention of CAD in subjects with elevated cholesterol levels. More recently, the efficacy of statins has been extended to the primary prevention of CAD in subjects with average cholesterol levels. Recent studies also suggest that statins have benefits beyond the coronary vascular bed and are capable of reducing ischemic stroke risk by approximately one-third in patients with evidence of vascular disease. In addition to lowering low-density lipoprotein (LDL) cholesterol, statin therapy appears to exhibit pleiotropic effects on many components of atherosclerosis including plaque thrombogenicity, cellular migration, endothelial function and thrombotic tendency. Growing clinical and experimental evidence indicates that the beneficial actions of statins occur rapidly and yield potentially clinically important anti-ischemic effects as early as one month after commencement of therapy. Future investigations are warranted to determine threshold LDL values in primary prevention studies, and to elucidate effects of statins other than LDL lowering. Finally, given the rapid and protean effects of statins on determinants of platelet reactivity, coagulation, and endothelial function, further research may establish a role for statin therapy in acute coronary syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 1×
“Trials with nonstatin compounds such as the Lipid Research Clinics Coronary Primary Prevention Trial using cholestyramine (5), and the Helsinki Heart Study (6) using gemfibrozil, supported this hypothesis and demonstrated significant reductions in coronary events.”
MethodThe Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Compensatory Enlargement of Human Atherosclerotic Coronary Arteries
Glagov, S., Weisenberg, E., Zarins, C. K., Stankunavicius, R., & Kolettis, G. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162204 · Cited by 3,623
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
RICHARDSON, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90953-7 · Cited by 1,258
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Platelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141 · cited 1×
“Platelets play a fundamental role in atherogenesis and in the pathophysiology of acute coronary syndromes (71,72).”
BackgroundIso, H., Jacobs, D. R., Wentworth, D., Neaton, J. D., Cohen, J. D., & for the MRFIT Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201405 · Cited by 1,133
Davies, M. J., Richardson, P. D., Woolf, N., Katz, D. R., & Mann, J. (1993) · Heart · doi:10.1136/hrt.69.5.377 · Cited by 1,127
Anderson, T. J., Meredith, I. T., Yeung, A. C., Frei, B., Selwyn, A. P., & Ganz, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320802 · Cited by 1,109
Treasure, C. B., Klein, J. L., Weintraub, W. S., Talley, J. D., Stillabower, M. E., Kosinski, A. S., Zhang, J., Boccuzzi, S. J., Cedarholm, J. C., & Alexander, R. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320801 · Cited by 1,097
&NA; (1996) · Journal of Occupational & Environmental Medicine · doi:10.1097/00043764-199605000-00005 · Cited by 1,070
(1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360301 · Cited by 970
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
O'Driscoll, G., Green, D., & Taylor, R. R. (1997) · Circulation · doi:10.1161/01.cir.95.5.1126 · Cited by 952
Furberg, C. D., Adams, H. P., Applegate, W. B., Byington, R. P., Espeland, M. A., Hartwell, T., Hunninghake, D. B., Lefkowitz, D. S., Probstfield, J., & Riley, W. A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1679 · Cited by 867
The Cellular Functions of Small GTP-Binding Proteins
Hall, A. (1990) · Science · doi:10.1126/science.2116664 · Cited by 867
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
Jukema, J. W., Bruschke, A. V. G., van Boven, A. J., Reiber, J. H. C., Bal, E. T., Zwinderman, A. H., Jansen, H., Boerma, G. J. M., van Rappard, F. M., & Lie, K. I. (1995) · Circulation · doi:10.1161/01.cir.91.10.2528 · Cited by 842
Brown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 821
(1998) · Circulation · doi:10.1161/01.cir.97.15.1440 · Cited by 796
O'Brien, K. D., Allen, M. D., McDonald, T. O., Chait, A., Harlan, J. M., Fishbein, D., McCarty, J., Ferguson, M., Hudkins, K., & Benjamin, C. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116670 · Cited by 703
Statins do more than just lower cholesterol
Vaughan, C. J., Murphy, M. B., & Buckley, B. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05190-2 · Cited by 698
Self-citationNavab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., et al. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.7.831 · Cited by 692
Callister, T. Q., Raggi, P., Cooil, B., Lippolis, N. J., & Russo, D. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392703 · Cited by 682
Quinn, M. T., Parthasarathy, S., & Steinberg, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2805 · Cited by 650
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
MAAS Investigators (1994) · The Lancet · doi:10.1016/s0140-6736(94)92082-6 · Cited by 647
Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00002 · Cited by 637
Armstrong, V. W., Cremer, P., Eberle, E., Manke, A., Schulze, F., Wieland, H., Kreuzer, H., & Seidel, D. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90099-7 · Cited by 626
Pedersen, T. R., Olsson, A. G., Færgeman, O., Kjekshus, J., Wedel, H., Berg, K., Wilhelmsen, L., Haghfelt, T., Thorgeirsson, G., Pyörälä, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.15.1453 · Cited by 621
Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
Crouse, J. R., Byington, R. P., Bond, M. G., Espefand, M. A., Craven, T. E., Sprinkle, J. W., McGovern, M. E., & Furberg, C. D. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80580-3 · Cited by 609
Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques
Toschi, V., Gallo, R., Lettino, M., Fallon, J. T., Gertz, S. D., Ferna´ndez-Ortiz, A., Chesebro, J. H., Badimon, L., Nemerson, Y., Fuster, V., et al. (1997) · Circulation · doi:10.1161/01.cir.95.3.594 · Cited by 603
Egashira, K., Hirooka, Y., Kai, H., Sugimachi, M., Suzuki, S., Inou, T., & Takeshita, A. (1994) · Circulation · doi:10.1161/01.cir.89.6.2519 · Cited by 597
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.
Henney, A. M., Wakeley, P. R., Davies, M. J., Foster, K., Hembry, R., Murphy, G., & Humphries, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8154 · Cited by 590
Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
Tamai, O., Matsuoka, H., Itabe, H., Wada, Y., Kohno, K., & Imaizumi, T. (1997) · Circulation · doi:10.1161/01.cir.95.1.76 · Cited by 542
Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase
Liao, J. K., Shin, W. S., Lee, W. Y., & Clark, S. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.319 · Cited by 541
Waters, D., Higginson, L., Gladstone, P., Kimball, B., Le May, M., Boccuzzi, S. J., & Lespérance, J. (1994) · Circulation · doi:10.1161/01.cir.89.3.959 · Cited by 499
Grundy, S. M. (1994) · Circulation · Cited by 477
Lacoste, L., Lam, J. Y. T., Hung, J., Letchacovski, G., Solymoss, C. B., & Waters, D. (1995) · Circulation · doi:10.1161/01.cir.92.11.3172 · Cited by 441
Pitt, B., Mancini, G. B. J., Ellis, S. G., Rosman, H. S., Park, J.-S., & Mcgovern, M. E. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00301-0 · Cited by 429
Weber, C., Erl, W., Weber, K. S. C., & Weber, P. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00324-0 · Cited by 411
Sacks, F. M., Moyé, L. A., Davis, B. R., Cole, T. G., Rouleau, J. L., Nash, D. T., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.97.15.1446 · Cited by 376
Rosenkranz-Weiss, P., Sessa, W. C., Milstien, S., Kaufman, S., Watson, C. A., & Pober, J. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117221 · Cited by 362 · cited 1×
“Hypercholesterolemia also reduces eNOS activity through cytokine production (67), or increases in dimethyl arginine, an endogenous inhibitor of eNOS (68).”
BackgroundColli, S., Eligini, S., Lalli, M., Camera, M., Paoletti, R., & Tremoli, E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.265 · Cited by 348
HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.
Kostner, G. M., Gavish, D., Leopold, B., Bolzano, K., Weintraub, M. S., & Breslow, J. L. (1989) · Circulation · doi:10.1161/01.cir.80.5.1313 · Cited by 340
Gould, K. L., Martucci, J. P., Goldberg, D. I., Hess, M. J., Edens, R. P., Latifi, R., & Dudrick, S. J. (1994) · Circulation · doi:10.1161/01.cir.89.4.1530 · Cited by 336
Acks, M. S., Arc, M., Feffer, A. P., Emuel, L., Oyé, A. M., Ouleau, J. E. L. R., Utherford, J. O. D. R., Ole, T. H. G. C., Rown, L. I. B., Arnica, J. W. A. W., et al. (1996) · Cited by 321
Herd, J. A., Ballantyne, C. M., Farmer, J. A., Ferguson, J. J., Jones, P. H., West, M. S., Gould, K. L., & Gotto, A. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00346-9 · Cited by 315
Self-citationBlauw, G. J., Lagaay, A. M., Smelt, A. H. M., & Westendorp, R. G. J. (1997) · Stroke · doi:10.1161/01.str.28.5.946 · Cited by 311
Effects of Lowering Elevated LDL Cholesterol on the Cardiovascular Risk of Lipoprotein(a)
Maher, V. M. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220037029 · Cited by 298
Notarbartolo, A., Davı̀, G., Averna, M., Barbagallo, C. M., Ganci, A., Giammarresi, C., Placa, F. P. L., & Patrono, C. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.247 · Cited by 259
Parhami, F., Fang, Z. T., Fogelman, A. M., Andalibi, A., Territo, M. C., & Berliner, J. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116590 · Cited by 257
MacMahon, S., Sharpe, N., Gamble, G., Hart, H., Scott, J., Simes, J., & White, H. (1998) · Circulation · doi:10.1161/01.cir.97.18.1784 · Cited by 254
Lewis, S. J., Sacks, F. M., Mitchell, J. S., East, C., Glasser, S., Kell, S., Letterer, R., Limacher, M., Moye, L. A., Rouleau, J. L., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00202-2 · Cited by 232
Reductase Inhibitor Monotherapy and Stroke Prevention
Crouse, J. R. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.12.1305 · Cited by 221
Effect of Cholesterol Reduction on Myocardial Ischemia in Patients With Coronary Disease
Andrews, T. C., Raby, K., Barry, J., Naimi, C. L., Allred, E., Ganz, P., & Selwyn, A. P. (1997) · Circulation · doi:10.1161/01.cir.95.2.324 · Cited by 220
Nègre-Aminou, P., van Vliet, A. K., van Erck, M., van Thiel, G. C. F., van Leeuwen, R. E. W., & Cohen, L. H. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00184-1 · Cited by 212
Chen, L., Haught, W. H., Yang, B., Saldeen, T. G. P., Parathasarathy, S., & Mehta, J. L. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00158-7 · Cited by 208
Effects of Fluvastatin on Leukocyte–Endothelial Cell Adhesion in Hypercholesterolemic Rats
Kimura, M., Kurose, I., Russell, J., & Granger, D. N. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.8.1521 · Cited by 193
van Boven, A. J., Jukema, J. W., Zwinderman, A. H., Crijns, H. J. G. M., Lie, K. I., & Bruschke, A. V. G. (1996) · Circulation · doi:10.1161/01.cir.94.7.1503 · Cited by 163
Vascular Effects of Statins in Stroke
Delanty, N., & Vaughan, C. J. (1997) · Stroke · doi:10.1161/01.str.28.11.2315 · Cited by 151
Self-citationAviram, M., Dankner, G., Cogan, U., Hochgraf, E., & Brook, J. G. (1992) · Metabolism · doi:10.1016/0026-0495(92)90263-a · Cited by 143
Huttunen, J. K., Frick, M. H., Heinonen, O. P., Heinsalmi, P., Manninen, V., Mänttäri, M., & Romo, M. (1988) · Drugs · doi:10.2165/00003495-198800363-00009 · Cited by 132
Induction of P-Selectin by Oxidized Lipoproteins
Vora, D. K., Fang, Z.-T., Liva, S. M., Tyner, T. R., Parhami, F., Watson, A. D., Drake, T. A., Territo, M., & Berliner, J. A. (1997) · Circulation Research · doi:10.1161/01.res.80.6.810 · Cited by 128
Regazzi, M. B., Iacona, I., Campana, C., Raddato, V., Lesi, C., Perani, G., Gavazzi, A., & Viganò, M. (1993) · PubMed · Cited by 114
Effects of long-term treatment with lovastatin on the clotting system and blood platelets
Mayer, J., Eller, T., Brauer, P., Solleder, E. M., Schäfer, R. M., Keller, F., & KOCHSIEK, K. (1992) · Annals of Hematology · doi:10.1007/bf01696223 · Cited by 111
Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease
Eichstädt, H. W., Eskötter, H., Hoffmann, I., Amthauer, H., & Weidinger, G. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80033-5 · Cited by 106
Bestehorn, H.-P., Rensing, U. F. E., Roskamm, H., Betz, P., Benesch, L., Schemeitat, K., Blümchen, G., Claus, J., Mathes, P., KAPPENBERGER, L. J., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015224 · Cited by 99
Low-Density Lipoproteins Inhibit the Na+/H+Antiport in Human Platelets
Nofer, J., Tepel, M., Kehrel, B. E., Wierwille, S., Walter, M., Seedorf, U., Zidek, W., & Assmann, G. (1997) · Circulation · doi:10.1161/01.cir.95.6.1370 · Cited by 97
Platelet-Dependent Thrombin Generation in Patients With Hyperlipidemia
Aoki, I., Aoki, N., Kawano, K., Shimoyama, K., Maki, A., Hòmori, M., Yanagisawa, A., Yamamoto, M., Kawai, Y., & Ishikawa, K. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00129-0 · Cited by 93
Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia
Wada, H., Mori, Y., Kaneko, T., Wakita, Y., Nakase, T., Minamikawa, K., Ohiwa, M., Tamaki, S., Tanigawa, M., Kageyama, S., et al. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830440208 · Cited by 90
Isoprenoid metabolism is required for stimulation of the respiratory burst oxidase of HL-60 cells.
Bokoch, G., & Prossnitz, V. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115599 · Cited by 86
Direct Effects of Statins on the Vascular Wall
Corsini, A., Pazzucconi, F., Arnaboldi, L., Pfister, P., Fumagalli, R., Paoletti, R., & Sirtori, C. R. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199805000-00017 · Cited by 86
Pasternak, R. C., Brown, L. E., Stone, P. H., Silverman, D. I., Gibson, C. M., Sacks, F. M., & Harvard Atherosclerosis Reversibility Project (HARP) Study Group (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00001 · Cited by 85
Badimón, J. J., Badimón, L., Turitto, V. T., & Fuster, V. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.395 · Cited by 83
Arginine: A New Therapy for Atherosclerosis?
Cooke, J. P., & Tsao, P. S. (1997) · Circulation · doi:10.1161/01.cir.95.2.311 · Cited by 82
Sang, K. L. Q., Levenson, J. A., Mégnien, J. L., Simon, A. C., & Devynck, M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.6.759 · Cited by 81
Use of Niacin, Statins, and Resins in Patients With Combined Hyperlipidemia
Brown, B. G., Zambon, A., Poulin, D., Rocha, A., Maher, V. M. G., Davis, J., Albers, J. J., & Brunzell, J. D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00039-3 · Cited by 63
Lundstam, U., Hurt‐Camejo, E., Olsson, G., Sartipy, P., Camejo, G., & Wiklund, O. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1162 · Cited by 62
Effect of simvastatin on coronary atheroma
Allen, T. W. (1994) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.1994.94.11.912c · Cited by 51
Effects of flwastatin on growth of porcine and human vascular smooth muscle cells in vitro
Rogler, G., Lackner, K. J., & Schmitz, G. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80031-1 · Cited by 45
Baldassarre, D., Mores, N., Colli, S., Pazzucconi, F., Sirtori, C. R., & Tremoli, E. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90104-1 · Cited by 23
Cited by
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
Schachter, M. (2005) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00299.x · Cited by 1,211
Leon, A. S., Franklin, B. A., Costa, F., Balady, G. J., Berra, K. A., Stewart, K. J., Thompson, P. D., Williams, M. A., & Lauer, M. S. (2005) · Circulation · doi:10.1161/01.cir.0000151788.08740.5c · Cited by 1,063
Metadata
- Authors
- Vaughan, C. J., Gotto, A. M., & Basson, C. T.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2000-01
- Volume
- 35
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2076834039
- Cited by
- 574
- References
- 93
- FWCI
- 48.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.